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Abstract: Background and objectives: The aim of this study is to propose a methodology that combines
non-invasive functional modalities electroencephalography (EEG) and single photon emission
computed tomography (SPECT) to estimate the location of the epileptogenic zone (EZ) for the
presurgical evaluation of patients with drug-resistant non-lesional epilepsy. Materials and Methods:
This methodology consists of: (i) Estimation of ictal EEG source imaging (ESI); (ii) application of the
subtraction of ictal and interictal SPECT co-registered with MRI (SISCOM) methodology; and (iii)
estimation of ESI but using the output of the SISCOM as a priori information for the estimation of the
sources. The methodology was implemented in a case series as an example of the application of this
novel approach for the presurgical evaluation. A gold standard and a coincidence analysis based
on measures of sensitivity and specificity were used as a preliminary assessment of the proposed
methodology to localize EZ. Results: In patients with good postoperative evolution, the estimated EZ
presented a spatial coincidence with the resection site represented by high values of sensitivity and
specificity. For the patient with poor postoperative evolution, the methodology showed a partial
incoherence between the estimated EZ and the resection site. In cases of multifocal epilepsy, the
method proposed spatially extensive epileptogenic zones. Conclusions: The results of the case series
provide preliminary evidence of the methodology’s potential to epileptogenic zone localization in
non-lesion drug-resistant epilepsy. The novelty of the article consists in estimating the sources of ictal
EEG using SISCOM result as a prior for the inverse solution. Future studies are necessary in order to
validate the described methodology. The results constitute a starting point for further studies in order
to support the clinical reliability of the proposed methodology and advocate for their implementation
in the presurgical evaluation of patients with intractable non-lesional epilepsy.
Keywords: EEG inverse solution; SPECT; SISCOM; epilepsy surgery; multimodal imaging
1. Introduction
About 20%–30% of people with epilepsy have resistance to treatment with antiepileptic drugs [1].
The surgical procedure is a therapeutic option for some of these patients with refractory drug-resistant
epilepsy. The success of surgical treatment depends on the accurate and confident identification of
the epileptogenic zone (EZ), its extension and its relationship with adjacent functional areas. This
becomes a great challenge for patients with no or subtle magnetic resonance imaging lesions or
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with ambiguous electro-clinical signs. Various non-invasive methods to determine the surgery site,
including clinical semiology, interictal/ictal video electroencephalography (EEG), magnetic resonance
imaging (MRI) are essential. Single photon emission computed tomography (SPECT) and positron
emission tomography (PET) are performed as additional tests in cases with “non-lesional” MRI and
non-concordant electro-clinical findings. Also, intracranial EEG is often used to localize the area
responsible for seizure, but this technique is invasive and cannot sample the activity from the whole
brain. A deeper presurgical evaluation with non-invasive approaches and technologies is required in
the attempt of identifying the EZ, the eloquent cortical areas and, consequently, the optimal resective
surgical strategy.
The brain perfusion ictal and interictal single-photon emission computed tomography (SPECT)
together with the subtraction of ictal and interictal SPECT co-registered with MRI (SISCOM) are
valuable noninvasive tools in the presurgical evaluation of patients with medically intractable epilepsies.
These images offer a high criterion of veracity in ictal onset detection represented by an increase in
cerebral blood perfusion [2]. Previous studies have reported a sensitivity of interictal SPECT around
44%, and ictal over 97% in temporal lobe epilepsy, contrary to a sensitivity of 66% in ictal and 40%
interictal in extra-temporal epilepsy [3]. On the other hand, ictal electroencephalography (EEG) source
imaging (ESI) allow us to infer the configuration of neuronal sources responsible for ictal activity.
Several methods and inverse solutions have been proposed for source imaging of epileptiform EEG
activity [4–6]. Due to the underdetermined nature of the inverse problem, each method operates
with specific additional constraints in order to localize the source. The solution can only be found
using additional information (spatial or temporal) on the sources of current either as a function of the
geometric or physiological properties of the brain, which can be included as restrictions [7]. For a
review on these methods see [8].
The objective of this article is to propose a methodology that combines non-invasive functional
modalities EEG and SPECT in identifying and localizing the epileptogenic zone for the presurgical
evaluation of patients with drug-resistant non-lesional epilepsy. This article presents a case series
as an example of the application of this novel approach. A gold-standard is established as an initial
assessment of methodology’s potential to localize EZ based on Engel scale and spatial coincidence
of estimated EZ with the resection site. No previous studies were found using SISCOM output as a
spatial restriction for the estimation of EEG sources.
This article illustrates the methodology follow up for the presurgical evaluation in the first Cuban
comprehensive surgery program carried out at the International Center for Neurological Restoration
in Havana, Cuba [9].
2. Materials and Methods
2.1. Case Series
The proposed methodology is applied, retrospectively, to five patients (Table 1) diagnosed with
drug resistant refractory epilepsy with complex partial seizures refractory to pharmacological treatment.
These patients belong to the aforementioned epilepsy research protocol. For the presurgical evaluation,
an ictal and inter-ictal video electroencephalogram was performed, as well as magnetic resonance
studies, neuropsychological evaluation and semiology of the seizures. Taking into account that MRI
showed no visible epileptogenic lesion and discordant results of electro-clinical evaluation without a
clear EZ hypothesis, an ictal study and an inter-ictal study of brain perfusion SPECT was performed.
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Table 1. Demographic and clinical data of the sample.




1 35 Male Temporal Right temporal Right temporal I
2 38 Male Temporal Left temporal Left temporal I
3 17 Male Extra-temporal Right frontal Right frontal III
4 39 Female Extra-temporal Right frontal andleft temporal No surgery -
1
5 29 Male Extra-temporal Bilateralfronto-temporal No surgery -
1
1 Patients not operated. EZ, epileptogenic zone.
Postsurgical outcome one year after surgery was evaluated according to the modified Engel
classification, Engel I outcome patients (favorable outcome) versus Engel II–IV outcome patients
(unfavorable outcome). Additionally, each patient who underwent surgery had an MRI one year
after surgery.
Patients were included in this study if they (1) had undergone both ictal and interictal SPECT
imaging before surgery, (2) had a volumetric preoperative MRI, and (3) had a volumetric postsurgical
MRI 1 year after surgery.
All the procedures followed the rules of the Declaration of Helsinki of 1975 for human research,
and the study was approved by the scientific and ethics committee from the International Center for
Neurological Restoration (CIREN37/2012).
2.2. SPECT and SISCOM
A brain perfusion SPECT was performed for all subjects, with the same gamma camera, and under
the same conditions. Each patient underwent two studies (Ictal and Inter-ictal) of brain perfusion
SPECT using 99mTc-ethylene-cysteine dimer (ECD). In both studies during the administration of
the radiopharmaceutical, the patient remained monitored by EEG. For inter-ictal SPECT, the dose is
administered with the patient at rest and with a seizure-free period of more than 24 h. For ictal SPECT,
the radiopharmaceutical was injected when the onset of a crisis with EEG is recognized. SPECT image
acquisition was performed using a double-headed gamma camera (SMV DST-XLi, Buc Cedex, France)
equipped with a fan-beam collimator. One hundred and twenty-eight projections in a circular orbit
of 360◦ per subject were collected in matrices of 128 × 128 pixels and with an energy window of 20%
centered on the photopeak of 99 mTc. Tomographic 3D reconstruction was performed using a DROSEM
algorithm. The SISCOM methodology was carried out, according to O’Brien et al. [10]. Ictal and
interictal SPECT studies were co-registered using an automatic registration algorithm based on mutual
information using the registration module of Statistical Parametric Mapping (SPM version 8; Wellcome
Trust Centre for Neuroimaging, London, UK), implemented in Matlab (R2014a; The MathWorks Inc.,
Natick, MA, USA). Each SPECT volume was multiplied by a binary mask to remove the extracerebral
activity. The ictal and spatially co-registered interictal images were then normalized for global brain
counts within each scan. The transformed, normalized interictal images were subtracted from the
normalized ictal image to create an image where the value for each pixel represents the intensity
difference between the two data sets. The difference image was smoothed using a 3D-Gaussian
smoothing kernel (full width at half maximum = 12 mm) and transformed into a z-score using the mean
and standard deviation (SD) of the differences in all brain voxels. (z-score = 2). For co-registration with
the MRI scan, the cerebral surface of the MRI volume was segmented from the extracerebral structures.
The cerebral surface of the binary ictal SPECT was then matched to the cerebral surface of the binary
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MRI. The resulting transformation matrix was applied to the subtraction SPECT to co-register it to the
cerebral surface of the MRI.
2.3. Inverse Solution from Ictal EEG
The cortical generators of EEG measurements can be estimated by solving an inverse imaging
problem where the unknown sources are distributed on an individual’s cortex. The methodology
followed for the estimation of the inverse solution of ictal EEG using EEGLAB MATLAB toolbox
consists of:
(1) source space definition in order to model the link between the EEG measurements and cortical
activity. Because the generators of the signals are believed to be mainly cortical, the source
space is given- by the triangularized inner cortical surface (gray matter/white matter interface),
segmented from individual patient’s T1-weighted 3D MRI;
(2) the spatial co-registration of the measurement electrodes to the using the Montreal Neurological
Institute (MNI; Montreal, Quebec, Canada) MNI152 template using translation and rotation;
(3) forward modeling of the cortical currents: To model the relationship between the source space
and the EEG measurements at the sensor level. The source space, the 3D electrode locations,
and the individually defined boundaries are then combined to characterize the electric field
propagation with a three-compartment boundary element method (BEM) [11]; and finally
(4) inversion of the model for source estimation using the Multiple Sparse Priors (MSP) algorithm [4].
2.4. SISCOM as Spatial Priors for Inverse Solution of Ictal EEG
Currently, the available priors in ESI gain from MRI, functional MRI and PET [12,13]. In this
paper we propose to use SPECT as a way to constrain the EEG source location on the assumption
that a subset of the neuronal activity is detectable by both modalities. Thus, the SISCOM result can
be used to inform the source localization method about the location of the sources. SISCOM images
reveal ictal hyperperfusion, which should correspond to the onset zone of epileptogenic crisis. This
restriction is based on the conjecture that synaptic currents that generate EEG signals also impose
metabolic demand, which leads to an increase in cerebral blood flow as measured by SPECT. Steps 1 to
3 are the same as above but, in addition to the mathematical priors, the ictal hyperperfusion derived
from SISCOM is considered to constraint ictal EEG source location:
(1) source space definition in order to model the link between the EEG measurements and cortical
activity. Because the generators of the signals are believed to be mainly cortical, the source
space is given- by the triangularized inner cortical surface (gray matter/white matter interface),
segmented from individual patient’s T1-weighted 3D MRI;
(2) the spatial co-registration of the measurement electrodes to the using the Montreal Neurological
Institute (MNI; Montreal, Quebec, Canada) MNI152 template using translation and rotation;
(3) forward modeling of the cortical currents: To model the relationship between the source space
and the EEG measurements at the sensor level. The source space, the 3D electrode locations,
and the individually defined boundaries are then combined to characterize the electric field
propagation with a three-compartment boundary element method (BEM) [11];
(4) Functional area definition using SPECT: To localize the functional areas using SISCOM
methodology that will be used to constrain the inverse procedure;
(5) SISCOM-informed inverse modeling of the cortical currents: To use the ictal hyperperfusion area
derived from SISCOM to constrain the estimation of the cortical activity generating the EEG
measurements using MSP algorithm.
2.5. Coincidence Analysis
For the present case series, a coincidence analysis was performed as an initial evaluation of
methodology. The three EZ proposed by the methodology: SISCOM, ictal ESI and ictal ESI using
Medicina 2019, 55, 478 5 of 10
SISCOM as a prior, were co-registered with the post-surgery anatomical image T1. Also, the results
were co-registered with AAL atlas [14] to identify anatomical regions corresponding to surgical
resection. A gold-standard was established to evaluate the veracity of the estimated EZ. Engel I
outcome (crisis-free) one year after surgery and a spatial intersection of the hypothetical EZ with
the resection site was established as a gold-standard. The spatial concordance was evaluated using









A low sensitivity would indicate many false negatives. On the other hand, the specificity reflects
the methodology’s capacity to not reporting false positives.
3. Results
Five patients were evaluated with this methodology, and three patients were subjected to surgical
treatment. Two patients (patients 1 and 2) had a favorable outcome (Engel I). In these two cases, the EZ
estimated by the proposed methodology shows spatial coincidence with the resection site represented
by high values of sensitivity, as well as specificity (Table 2). For both patients, SISCOM result consisted
of a single confined region that correspond to the resection site but without covering it completely
(Figure 1 in red). Ictal ESI (Figure 1 in blue) consisted in a region more extended than SISCOM outcome,
but also includes voxels that corresponded to false positives. Ictal ESI using SISCOM as a prior revealed
a region, including more voxels of the resection site than SISCOM and ictal ESI individually, but
also false positives, due to ictal ESI outcome (Figure 1 in green). These results are quantified in the
coincidence analysis, and high sensitivity values were obtained for ictal ESI (82.1%), SISCOM (65%)
and ictal ESI + SISCOM (92.6%), and only high specificity for the SISCOM case (99.9%) (Table 2).
Table 2. Coincidence analysis of estimated EZ with the resection site.
Patient
Sensibility Specificity
SISCOM Ictal ESI Ictal ESI + SISCOM SISCOM Ictal ESI Ictal ESI + SISCOM
1 65% 82.1% 92.6% 99.9% 46.4% 61.7%
2 55.2% 58.7% 83.4% 99.9% 43.9% 65%
3 3.5% 44.6% 49% 52.9% 47.4% 48.5%
Patient 3 underwent surgery for the resection of the right frontal lobe. Unfortunately, the patient
had an unfavorable outcome (Engel III), which indicates recurrence seizures. Two regions were
identified with SISCOM methodology (Figure 2 in red), one that most of the voxels remained posterior
to resection site; and the other corresponding to para-hippocampus and fusiform gyrus. The ictal ESI
revealed voxels that coincide to the resection site but also voxels that were posterior to it (Figure 2 in
blue) and voxels of the frontal pole in the opposite hemisphere. The ictal ESI using SISCOM as a prior
proposed voxel that coincide with the resection site but also voxels that remain posterior to it (Figure 2
in green); in addition to the voxels that correspond to the para-hippocampus and fusiform gyrus, due
to SISCOM restriction. Low values of both sensitivity and specificity were obtained for this patient
(Table 2).
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Figure 2. EZ estimated by the proposed meth l -registered to post-operative T1-weighted
MRI: SISCOM (in red), ictal ESI (blue) and ictal ESI using SISCOM as a prior (green) for patient 3. The
white arrow indicates the resection site.
Patients 4 and 5 ere diagnosed with extra-temporal epilepsy and, as the rest of patients, did
not present appreciable lesions in the structural MRI. Both cases were diagnosed with multifocal
epilepsy, and they were not subjected to surgical intervention. The estimation of the sources from
ictal ESI revealed extensive cortical zones that includes bilateral temporal and frontal lobes for both
cases (Figure 3 in blue). SISCOM results showed confined regions in the right frontal and left temporal
for patient 4 (Figure 3a in red) and in frontal and temporal lobes bilaterally for patient 5 (Figure 3b
in red). Ictal ESI incorporating SISCOM as a prior (Figur 3 in gr en) c nsisted of scattered zones
in both h misp eres and lobes (temporal a d fr ntal). Unlike the previous cases, it is not possible
to determine spatially confined EZ. The methodology proposes scattered and diverse EZ, which is
consistent with the diagnosis of multifocal epilepsy.
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4. Discussion
In the present work, we propose a methodology that combines different functional neuroimaging
techniques to identify epileptogenic zone (EZ) in patients with drug-resistant non-lesional epilepsy.
Single-photon emission computed tomography (SPECT), subtraction of ictal and interictal SPECT
co-registered with MRI (SISCOM), and ictal electroencephalography (EEG) source imaging (ESI)
are complementary diagnostic methods in the localization of seizure zone when MRI is negative.
The novelty of the article consists in estimatin the sources of ictal EEG using SISCOM result s
a pri r for th inverse solution. T e are o r se rch records that u e SPECT-SISCOM as a prior
for ictal ESI in the consulted literature. A c se series is presented to imple nt the described
methodology. A gold-standard of value I on the Engel scale and spatial coincidence of estimated EZ
with the resection site was established for postsurgical evaluation of patients. The spatial coincidence
analysis allows a preliminary quantitative evaluation of the methodology based on sensitivity and
specificity measurements.
Five patients were evaluated with this methodology, and three patients were subjected to surgical
treatment. Two patients had favorable outcome (Engel I). In these two cases (patients 1 and 2) the
methodology propos d EZ that coincide spatially ith the resectio site represented b high values
of sensitivity, as well as spec ficity (Table 2). The low specificity values of the ictal ESI are due to
fals positives.
The third patient underwent surgery did not have a favorable outcome with continued seizures
ensue (Engel III). The methodology reported EZ that were not included in the resection site for this
patient, instead were localized posterior it. For this particular case, low values of both sensitivity and
specificity were obtained.
The remaining two patients did not undergo surgery because they were diagnosed with multifocal
epilepsy after the presurgical evaluation. The implementation of our methodology for these two
patients proposed diverse and dispersed EZ that cover both hemispheres. This result demonstrates
that the methodology can be used not only in the cases of focal non-lesional epilepsy for determination
of EZ, but also in multifocal cases.
Medicina 2019, 55, 478 8 of 10
The proposed methodology estimates EZ by ictal ESI, SISCOM and ictal ESI using SISCOM as
prior. For the present case series, which was an initial test of the methodology, shows that the highest
values of the sensitivity of localizing EZ were obtained for ictal ESI using SISCOM as a prior. Due to
the spatial location of the neuronal sources of the scalp recorded EEG activity cannot be conclusively
determined (inverse problem has no unique solution) by introducing reasonable priors from other
modalities, inverse solution methods reveal the most probable sources and communication structures.
Further studies are necessary in order to conclude that combining EEG and SPECT allows less false
negatives, which would contribute to a better surgical outcome. Otherwise, SISCOM has the highest
specificity providing reliability by false positives. The objective of this work is not to evaluate the
veracity of the individual techniques used (ESI or SISCOM) to identify EZ in drug-resistant epilepsy,
which has been the goal of some publications [15–18]. The disadvantages of each individual technique
are balanced by establishing a methodology that uses and combines different functional modalities.
ESI methods provide an estimate of the resulting current density at each voxel that is a combination
of the real source values over all the voxels of the brain, which causes a remarkable distortion in the
estimation of sources. Therefore, ESI methods have the disadvantage of proposing spurious sources,
as well as a high level of spatial dispersion; and it is also ineffective in detecting the activation of
deep structures. This explains the presence of false positives and the inability of this method to detect
deep structures, such as amygdala and hippocampus. These drawbacks are not present in the case of
SISCOM methodology. However, the accuracy of the SISCOM has various seizure-related factors that
affect the localization of EZ; and the most significant one is timing tracer injection [19]. The delayed
injection may detect secondary hyper-perfusion, due to seizure spread, non-localized findings or even
false locations of EZ. The rapid propagation of ictal activity in certain seizures makes it difficult to select
the signals corresponding to the onset. SISCOM as a prior for ESI includes information about structures
not detectable with scalp EEG, because they are too deep. However, the more reliant SISCOM, the
more trust-able, would be the source estimations.
The major limitation of this study is the small sample size. Therefore, we anticipate that future
studies with increased sample size will be able to validate the proposed methodology. Nonetheless,
the main value of this study is to outline a novel noninvasive approach combining MRI, SPECT and
EEG for the location of the epileptogenic zone in pharmacoresistant non-lesional epilepsy.
From the above discussion, it can be concluded that the proposed methodology may contribute to
epileptogenic zone localization in non-lesion drug-resistant epilepsy. The case series, although limited
by small sample size, suggests that combining ictal ESI and SISCOM has higher predictive value than
individual techniques for good outcomes. Before implementing SISCOM methodology or ictal ESI
methods, care must be taken their advantages and disadvantages. However, the fusion of the different
methodologies is helpful and give better results than implement only individual techniques.
5. Conclusions
The main aim of this paper is to a new methodology based on the integration of non-invasive
functional neuroimages to an accurate estimation of the source generating epileptiform discharges
for the presurgical evaluation of patients with drug-resistant focal epilepsy. The methods have been
oriented to the identification of the epileptogenic zone by the processing of ictal EEG and ictal and
inter-ictal SPECT. The methodology proposed offers relevant information about EZ in both temporal
and extra-temporal, focal and multifocal epilepsy. The major limitation of this study is the small
sample size. The case series results provide future study directions in order to validate the proposed
methodology and advocate for their implementation in the presurgical evaluation of patients with
intractable non-lesional epilepsy. The fusion of different non-invasive functional techniques on the
magnetic resonance imaging of the patient provides valuable information in identifying and localizing
the epileptogenic zone to be considered as a surgical resection site. Localizing information of one
modality may enhance detection of subtle abnormality in another modality.
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